EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus
According to international consensus, metformin is acknowledged as a first-line therapeutic agent for type 2 diabetes mellitus (T2DM). However, in most cases this treatment eventually requires intensification by supplementation with other hypoglycemic medications. The aim of the EDGE study (Effectiv...
| 1. Verfasser: | |
|---|---|
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
Endocrinology Research Centre
2013-06-01
|
| Schriftenreihe: | Сахарный диабет |
| Schlagworte: | |
| Online Zugang: | https://www.dia-endojournals.ru/jour/article/view/3761 |